You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-HLA DR + DP + DQ antibody [CR3/43] (ab7856)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-HLA DR + DP + DQ antibody [CR3/43]
See all HLA DR + DP + DQ products (5) ...

Description

Mouse monoclonal [CR3/43] to HLA DR + DP + DQ

Specificity

The gene of the human histocompatibility complex class II consists of at least four subregions: HLADP,DQ, and DR, containing a minimum of one alpha and one beta chain. This antibody reacts with the beta-chain of all products of the gene subregions DP, DQ, and DR.

Tested applications

IHC-P, IP, WBmore details

Cross reactivity

Reacts with

Human

Immunogen

Tonsil cells of Human origin

Properties

Form

Liquid

Storage instructions

Store at +4°C. Do not freeze.

Storage buffer

pH: 7.40
Preservative: 0.1% Sodium azide
Constituent: PBS

Concentration

Concentration information loading...

Purity

Protein G purified

Primary antibody notes

This antibody principally labels B cells, interdigitating reticulum cells, Langerhans’ cells and manymacrophages.

Clonality

Monoclonal

Clone number

CR3/43

Isotype

IgG1

Light chain type

kappa

Research areas

Immunology >> Adaptive Immunity >> MHC >> Class II

  • Western blot - HLA DR + DP + DQ antibody [CR3/43.] (ab7856)Western blot - HLA DR + DP + DQ antibody [CR3/43.] (ab7856) image (enlarge)

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - HLA DR + DP + DQ antibody [CR3/43] (ab7856)Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - HLA DR + DP + DQ antibody [CR3/43] (ab7856) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab7856 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • ShowHide1 Image

    IHC-P

     IHC-P: Use a concentrati...Read more →

    IHC-P: Use a concentration of 1 µg/mlPerform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

  • ShowHide

    IP

     IP: Use at an assay depe...Read more →

    IP: Use at an assay dependent concentration.

  • ShowHide1 Image

    WB

     WB: 1/500Detects a band ...Read more →

    WB: 1/500Detects a band of approximately 30 kDa (predicted molecular weight: 27 kDa).

Target

Function

Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accomodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins that access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenous antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, and for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal compartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also a source of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In addition to APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74 and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an antigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the ER to form an heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen processing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving a small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported to the cell membrane surface. In B cells, the interaction between HLA-DM and MHC class II molecules is regulated by HLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal miroenvironment has been implicated in the regulation of antigen loading into MHC II molecules, increased acidification produces increased proteolysis and efficient peptide loading.

Sequence similarities

Belongs to the MHC class II family.
Contains 1 Ig-like C1-type (immunoglobulin-like) domain.

Cellular localization

Cell membrane. Endoplasmic reticulum membrane. Golgi apparatus > trans-Golgi network membrane. Endosome membrane. Lysosome membrane. The MHC class II complex transits through a number of intracellular compartments in the endocytic pathway until it reaches the cell membrane for antigen presentation.

Target information above from: UniProt accessionP04440 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • DP beta 1 chain antibody
  • DP(W4) beta chain antibody
  • CD antibody
  • CELIAC 1 antibody
  • CELIAC1 antibody
  • DPB1 antibody
  • DPB1_HUMAN antibody
  • DQ A1 antibody
  • DRB1 antibody
  • DRB4 antibody
  • FLJ27088 antibody
  • FLJ27328 antibody
  • GSE antibody
  • HLA class II histocompatibility antigen antibody
  • HLA class II histocompatibility antigen DR 1 beta antibody
  • HLA class II histocompatibility antigen DR alpha antibody
  • HLA class II histocompatibility antigen DR alpha chain antibody
  • HLA DP histocompatibility type beta 1 subunit antibody
  • HLA DP1B antibody
  • HLA DPB1 antibody
  • HLA DQA antibody
  • HLA DQA1 antibody
  • HLA DQB antibody
  • HLA DQB1 antibody
  • HLA DR1B antibody
  • HLA DR3B antibody
  • HLA DR4B antibody
  • HLA DRA antibody
  • HLA DRA1 antibody
  • HLA DRB1 antibody
  • HLA DRB3 antibody
  • HLA DRB4 antibody
  • HLA DRB5 antibody
  • HLA-DPB1 antibody
  • IDDM 1 antibody
  • IDDM1 antibody
  • Major histocompatibility complex class II DP beta 1 antibody
  • Major histocompatibility complex class II DQ alpha 1 antibody
  • Major histocompatibility complex class II DQ beta 1 antibody
  • Major histocompatibility complex class II DR alpha antibody
  • Major histocompatibility complex class II DR beta 1 antibody
  • Major histocompatibility complex class II DR beta 3 antibody
  • Major histocompatibility complex class II DR beta 4 antibody
  • Major histocompatibility complex class II DR beta 5 antibody
  • MGC117330 antibody
  • MHC class II antigen DPB1 antibody
  • MHC class II antigen DRA antibody
  • MHC class II HLA DQ alpha 1 antibody
  • MHC class II HLA DR beta 1 antibody
  • MHC class II HLA DR beta 3 antibody
  • MHC DPB1 antibody
  • MHC DQ beta antibody
  • MHC HLA DPB1 antibody
  • MHC HLA DQ alpha antibody
see all

Anti-HLA DR + DP + DQ antibody [CR3/43] images:

  Western blot - HLA DR + DP + DQ antibody [CR3/43.] (ab7856)

Western blot - HLA DR + DP + DQ antibody [CR3/43.] (ab7856)

All lanes : Anti-HLA DR + DP + DQ antibody [CR3/43] (ab7856) at 1/500 dilution

Lane 1 : U-87 MG (Human glioblastoma astrocytoma) Whole Cell Lysate
Lane 2 : Liver (Human) Tissue Lysate - adult normal tissue (ab29889)
Lane 3 : Lung (Human) Tissue Lysate

Lysates/proteins at 10 µg per lane.

Secondary
Goat polyclonal to Mouse IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution

Predicted band size : 27 kDa
Observed band size : 30 kDa (why is the actual band size different from the predicted?)

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - HLA DR + DP + DQ antibody [CR3/43] (ab7856)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - HLA DR + DP + DQ antibody [CR3/43] (ab7856)

IHC image of ab7856 staining in human tonsil formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab7856, 1µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

References for Anti-HLA DR + DP + DQ antibody [CR3/43] (ab7856)

ab7856 has not yet been referenced specifically in any publications.

Publishing research using ab7856? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"